Legionnaires’ Disease /Pontiac Fever

About This Disease

Legionellosis is the general term for two distinct forms of illness caused by Legionella bacteria: Legionnaires’ disease, which can be severe and include pneumonia, and Pontiac fever, a mild flu-like illness.

Legionnaires’ disease was named in 1976 when an outbreak of pneumonia occurred among persons attending a convention of the American Legion in Philadelphia.

Signs and Symptoms

Onset of symptoms of Legionnaires’ disease typically occurs 5 or 6 days after exposure to Legionella bacteria, but the incubation period can range from 2 days to almost  2 weeks.

Early symptoms of Legionnaires’ disease include muscle aches, headache, loss of appetite, tiredness, and cough. These symptoms are often followed by chills, diarrhea, and high fever. Chest x-rays may indicate progressive pneumonia. It is difficult to distinguish the disease from other types of pneumonia by symptoms alone. Other tests are needed to diagnose the disease. Persons with Legionnaires’ disease often require hospitalization, and the disease is fatal in about 10% of cases.

Persons with Pontiac fever most often start to develop symptoms 24–48 hours after being exposed to Legionella bacteria, but symptom onset can range from a few hours up to 3 days. Symptoms of Pontiac fever include fever and muscle aches, with no pneumonia. In contrast to Legionnaires’ disease, Pontiac fever is not a potentially life-threatening illness.

Legionellosis

Transmission

Legionellosis is the most common cause of waterborne disease outbreaks in the United States. Infection occurs directly from the environment. You can get legionellosis through the air by breathing in mists from a water source containing the bacteria. The bacteria can be found naturally in fresh water environments such as lakes and streams, but human-made water systems—e.g., plumbing systems and hot water tanks, air-conditioning cooling towers, whirlpool spas—are the most frequently documented sources of human infection. Legionellosis is not associated with car or household window air conditioners.

Outbreaks occur when two or more individuals are exposed to Legionella bacteria in the same location and get sick around the same time. Outbreaks have been reported in association with buildings or structures that have complex water systems, such as hotels, hospitals, long-term care facilities, and cruise ships. The most likely sources of infection include water used for showering, hot tubs, decorative fountains, and cooling towers (parts of centralized air-conditioning systems for large buildings).

In general, Legionella infection is not spread from one person to another, but person-to-person transmission may be possible in rare cases.

Diagnosis

Most people with Legionnaires’ disease develop pneumonia, which is diagnosed by physical exam or by confirmatory findings on chest x-ray.

The Legionella urinary antigen test detects the presence in urine of Legionella pneumophila serogroup 1, the most common cause of legionellosis. If the patient has pneumonia and the urinary antigen test is positive, then the patient is considered to have Legionnaires’ disease. Culture (isolating and growing the bacteria on special media) of respiratory specimens is another important method used to diagnose this disease. Polymerase chain reaction (PCR) testing of lung tissue and other clinical specimens may also be performed for rapid diagnosis of pneumonia caused by Legionella bacteria.

Pontiac Fever can be confirmed by urine antigen or paired sera (blood specimens), but a negative test doesn’t rule out the diagnosis. It is often diagnosed clinically in the setting of other laboratory-confirmed legionellosis cases. Culture cannot be used to diagnose Pontiac Fever.

Treatment

A doctor can prescribe antibiotics to treat Legionnaires’ disease. People with Pontiac fever recover without specific treatment. Antibiotics apparently do not affect recovery time and so are not recommended to treat Pontiac Fever.

Risk in Hawaii

Cases and outbreaks of legionellosis are often associated with hotels and resorts, long-term care facilities, hospitals, cruise ships and other structures that have large, complex water systems and use aerosol-generating devices. Nationally, over 10-15% of reported cases of Legionnaires’ disease are travel-related.

Prevention

Because Legionella bacteria can be found in many places in the environment, there is very little an individual can do to prevent exposure. However, some preventive measures can be taken by industry to reduce the risks. These measures include improving the design and maintenance of plumbing systems and cooling towers, periodic draining and cleaning of cooling towers, and use of chemicals to prevent the growth and spread of Legionella bacteria in air conditioning cooling towers and evaporative condensers.

There are no vaccines that can prevent legionellosis.

Additional Resources

Centers for Disease Control and Prevention (CDC)

Legionnaires’ Disease Fact Sheet (CDC)

Hawaii State Department of Health Legionellosis Fact Sheet (PDF)

Centers for Disease Control and Prevention Environmental Investigation Videos

Disinfection of Hot Tubs Contaminated with Legionella

Facts about Legionella and Hot Tubs/Spas

Developing a Water Management Program to Reduce Legionella Growth & Spread in Buildings

Frequently Asked Questions on ASHRAE Standard 188: Legionellosis: Risk Management for Building Water Systems

Guidelines for Environmental Infection Control in Health-Care Facilities Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC, 2003; Last update: February 15, 2017).

Guidelines for Preventing Health-Care-Associated Pneumonia, 2003 — Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee

Environmental Assessment and Sampling for Engineers

Legionella Environmental Assessment Form

Sampling Procedure and Potential Sampling Sites

Sample Data Sheet for Environmental Samples Taken for Legionella Culture

Publications

Beer KD, Gargano JW, Roberts VA, et al. Outbreaks associated with environmental and undetermined water exposures — United States, 2011–2012MMWR Morb Mortal Wkly Rep. 2015;64(31):849–51.

Beer KD, Gargano JW, Roberts VA, et al. Surveillance for waterborne disease outbreaks associated with drinking water — United States, 2011–2012MMWR Morb Mortal Wkly Rep. 2015;64(31):842–8.

Benin AL, Benson RF, Arnold KE, et al. An outbreak of travel-associated Legionnaires’ disease and Pontiac fever: the need for enhanced surveillance of travel-associated legionellosis. J Infect Dis 2002;185:237–43.

Dooling KL, Toews KA, Hicks LA, et al.Active Bacterial Core surveillance for legionellosis – United States, 2011–2013MMWR Morb Mortal Wkly Rep. 2015;64(42):1190–3.

Garrison LE, Kunz JM, Cooley LA, et al.Vital Signs: Deficiencies in environmental control identified in outbreaks of Legionnaires’ disease – North America, 2000–2014MMWR Morb Mortal Wkly Rep. 65(22):576–84.

Kozak NA, Lucas CE, Winchell JM.Identification of Legionella in the environment [23 pages]. Methods Mol Biol. 2013;954:3–25.

Kunz J, Cooley L. Preventing Legionnaires’ disease: Environmental health expertise is key. J Environ Health. 2016;79(1):24–6.

American Society of Heating, Refrigerating and Air-Conditioning Engineers, Inc. ANSI/ASHRAE Standard 188-2018, Legionellosis: Risk Management for Building Water Systems. Publication may be purchased from ASHRAE.

Information for Clinicians

Centers for Disease Control and Prevention (CDC)

What Clinicians Need to Know about LEGIONNAIRES’ DISEASE

Diagnosis

Clinical features of Legionnaires’ disease include cough, fever, and radiographic pneumonia. Signs and symptoms for Legionnaires’ disease are similar to pneumonia caused by other pathogens; the only way to tell if a pneumonia patient has Legionnaires’ disease is by getting a specific diagnostic test. Indications that warrant testing include:

  • Patients who have failed outpatient antibiotic therapy for community-acquired pneumonia
  • Patients with severe pneumonia, in particular those requiring intensive care Immunocompromised patients with pneumonia
  • Patients with pneumonia in the setting of a Legionnaires’ disease outbreak
  • Patients with a travel history within 2 weeks before the onset of illness

Clinicians should also test patients with healthcare-associated pneumonia for Legionnaires’ disease. This is especially important among patients at increased risk for developing Legionnaires’ disease, among patients with severe pneumonia (in particular those requiring intensive care), or if any of the following are identified in your facility:

  • Patients with Legionnaires’ disease, no matter where they acquired the infection
  • Positive environmental tests for Legionella
  • Changes in water quality that may lead to Legionella growth (such as low chlorine levels)

Use both a urinary antigen test and culture of a lower respiratory specimen when testing patients for Legionella. The preferred diagnostic tests for Legionnaires’ disease are culture of lower respiratory secretions on selective media and the Legionella urinary antigen test. Serological assays can be nonspecific and are not recommended in most situations. Best practice is to obtain lower respiratory specimens for culture at the time urinary antigen testing is ordered, preferably before the administration of antibiotics. The urinary antigen test detects Legionella pneumophila serogroup 1, the most common cause of Legionnaires’ disease; isolation of Legionella by culture is important for detection of other species and serogroups and for public health investigation. Molecular techniques can be used to compare clinical isolates to environmental isolates and confirm the outbreak source.

Treatment

If your patient has Legionnaires’ disease, see the most recent guidelines for treatment from CDC .

Reporting Procedures

URGENT category: HDOH requires that Hawaii Health Care Providers report cases of Legionellosis by calling (808) 586-4586. The telephone report should be followed by a written report (i.e., Communicable Disease Report) submitted by mail or fax to the Disease Investigation Branch or the applicable District Health Office within three days; respective mailing addresses and fax numbers are listed on the Communicable Disease Report form.

 

Last Reviewed: August 2022